Bivalirudin: all 55 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic TherapyNot yet recruitingNCT06861374Not applicable
• Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane OxygenationRecruitingNCT06275555Not applicable
• Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp SystemRecruitingNCT06080074Phase 2
• A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.RecruitingNCT05984537Phase 4
• BivaLirudin versUS Heparin in Extracorporeal Membrane OxygenationRecruitingNCT05959252Phase 2
• Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMOCompletedNCT03318393Phase 4Results posted
• Bivalirudin Infusion for Ventricular Infarction LimitationTerminatedNCT02565147Phase 3Results posted
• Simplified Anti-Thrombotic Therapy for FFRCompletedNCT02384070Not applicableResults posted
• ENDOvascular Interventions With AngioMAX: The ENDOMAX TrialTerminatedNCT01913483Phase 3Results posted
• Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFHCompletedNCT01651780Phase 3Results posted
• Antithrombotic Effects of Ticagrelor Versus ClopidogrelCompletedNCT01642238Phase 4Results posted
• How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary InterventionCompletedNCT01519518Phase 4Results posted
• European Ambulance Acute Coronary Syndrome (ACS) Angiography TrialCompletedNCT01087723Phase 3Results posted
• Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial InfarctionCompletedNCT00433966Phase 3Results posted
• Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 PatientsCompletedNCT05334654Not applicable
• Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial AneurysmsStatus unknownNCT04532333Phase 3
• Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMIStatus unknownNCT04475835Not applicable
• Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO TrialStatus unknownNCT04445935Phase 4
• Multi-center Application of Bivalirudin in Left Atrial Appendage OcclusionStatus unknownNCT04195997Phase 4
• Bivalirudin in Late PCI for Oatients With STEMIStatus unknownNCT04185077Phase 4
• Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.Status unknownNCT04046029Phase 4
• Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane OxygenationStatus unknownNCT03965208Phase 4
• Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial InfarctionStatus unknownNCT03882775Phase 4
• Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCICompletedNCT03822975Not applicable
• Bivalirudin vs Heparin in ECMO PatientsWithdrawnNCT03707418Phase 1
• Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCICompletedNCT03664180Phase 4
• Reduce Bolus Injection of BivalirudinCompletedNCT03588611Phase 4
• Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)Status unknownNCT03567408Phase 2
• A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular DysfunctionActive, not recruitingNCT03537586Not applicable
• Bivalirudin in Acute Myocardial InfarctionStatus unknownNCT02897037Phase 3
• Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCIStatus unknownNCT02787317Phase 4
• Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization TrialTerminatedNCT02448550Phase 3
• Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEARTCompletedNCT02311231Phase 4
• BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial.CompletedNCT01696110Phase 4
• Phase 1 Single Dose Escalation Study of CTB-001Status unknownNCT01647893Phase 1
• Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis TrialStatus unknownNCT01555658Phase 3
• Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding PatientsCompletedNCT01465503Phase 3
• Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary InterventionTerminatedNCT01464671Phase 4
• Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMIStatus unknownNCT01158846Phase 4
• EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of BleedingStatus unknownNCT01084993Phase 4
• Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial InfarctionStatus unknownNCT00976092Phase 4
• The UNBLOCK Study: Utilization of Bivalirudin On Clots in KidsCompletedNCT00812370Phase 1
• Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) PatientsWithdrawnNCT00759083Phase 4
• ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for BleedingCompletedNCT00616460Phase 3
• Bivalirudin as a Procedural Anticoagulant in PediatricsCompletedNCT00503126Phase 2
• Antithrombotic Regimens and OutcomeCompletedNCT00448461Phase 4
• Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)CompletedNCT00262054Phase 4
• Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCICompletedNCT00093184Phase 3
• Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)CompletedNCT00093158Phase 3
• Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)CompletedNCT00079586Phase 3
• Angiomax in Patients With HIT/HITTS Type II Undergoing CPBCompletedNCT00079508Phase 3
• Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCABCompletedNCT00073593Phase 3
• Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)CompletedNCT00073580Phase 3
• Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)CompletedNCT00043940Phase 3
• Study Of Angiomax In Infants Under Six Months With ThrombosisCompletedNCT00043277Phase 2

← Bivalirudin overview